CA Stock MarketDetailed Quotes
BRM Biorem Inc
- 3.000
- +0.020+0.67%
15min DelayMarket Closed Nov 29 16:00 ET
47.40MMarket Cap10.17P/E (TTM)
3.000High2.940Low15.59KVolume2.990Open2.980Pre Close46.28KTurnover3.39052wk High0.10%Turnover Ratio15.80MShares0.88052wk Low0.295EPS TTM47.06MFloat Cap3.790Historical High23.08P/E (Static)15.69MShs Float0.080Historical Low0.13EPS LYR2.01%Amplitude--Dividend TTM4.76P/B1Lot Size--Div YieldTTM
Biorem Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 170.19%14.89M | 70.57%7.3M | 86.73%5.92M | -12.81%25.17M | 11.88%12.21M | -24.61%5.51M | -31.67%4.28M | -27.65%3.17M | 17.91%28.86M | 0.66%10.91M |
| Operating revenue | 170.19%14.89M | 70.57%7.3M | 86.73%5.92M | -12.81%25.17M | 11.88%12.21M | -24.61%5.51M | -31.67%4.28M | -27.65%3.17M | 17.91%28.86M | 0.66%10.91M |
| Cost of revenue | 148.78%9.86M | 69.65%5.64M | 35.57%4.14M | -9.74%18.14M | 11.39%7.8M | -17.22%3.97M | -30.81%3.33M | -12.84%3.05M | 10.20%20.1M | -1.84%7M |
| Gross profit | 225.16%5.02M | 73.79%1.66M | 1,421.32%1.78M | -19.86%7.02M | 12.75%4.41M | -38.66%1.54M | -34.53%953.57K | -86.69%116.99K | 40.49%8.76M | 5.49%3.91M |
| Operating expense | 151.24%2M | 36.33%1.14M | 32.04%1.22M | -35.31%3.96M | -49.12%1.4M | -40.79%794.39K | -22.39%839.23K | -1.90%923.14K | 56.85%6.12M | 116.83%2.76M |
| Selling and administrative expenses | 151.77%1.99M | 35.30%1.13M | 30.53%1.2M | -32.50%3.91M | -45.82%1.36M | -39.45%789.55K | -19.94%835.62K | -0.98%922.12K | 47.85%5.79M | 98.28%2.51M |
| -Selling and marketing expense | 117.76%1.16M | 33.68%744.86K | 32.32%691.58K | -11.79%2.28M | -9.45%667.48K | -25.06%531.5K | -2.51%557.18K | -7.56%522.64K | 23.15%2.58M | 12.32%737.1K |
| -General and administrative expense | 221.83%830.46K | 38.55%385.77K | 28.18%512.07K | -49.21%1.63M | -60.97%690.72K | -56.61%258.05K | -41.04%278.44K | 9.20%399.49K | 76.38%3.2M | 191.06%1.77M |
| Research and development costs | 63.96%7.94K | 274.40%13.51K | 1,408.40%15.27K | -68.66%30.44K | 76.78%20.98K | -87.21%4.85K | -90.39%3.61K | -89.69%1.01K | 582.86%97.12K | 65.87%11.87K |
| Other operating expenses | ---- | ---- | ---- | -90.12%23.52K | ---- | ---- | ---- | ---- | 1,052.46%238.12K | ---- |
| Operating profit | 303.48%3.03M | 348.72%513.07K | 169.58%560.88K | 15.98%3.06M | 160.85%3M | -36.22%749.9K | -69.52%114.34K | -1,197.99%-806.15K | 13.14%2.64M | -52.68%1.15M |
| Net non-operating interest income (expenses) | 11.95%-47.43K | 24.85%-50.12K | 20.93%-50.95K | -6.32%-273.44K | -66.93%-88.45K | 21.20%-53.86K | -6.68%-66.69K | 12.13%-64.43K | -617.18%-257.18K | -2,407.62%-52.99K |
| Non-operating interest expense | -11.95%47.43K | -24.85%50.12K | -20.93%50.95K | 6.32%273.44K | 66.93%88.45K | -21.20%53.86K | 6.68%66.69K | -12.13%64.43K | 617.18%257.18K | 2,407.62%52.99K |
| Other net income (expenses) | 136.23%4.19K | 99.66%-607 | -138.33%-44.93K | 83.91%-11.55K | -100.99%-178.94K | 11,241.73%117.21K | ||||
| Gain on sale of security | ---- | 99.66%-607 | -138.33%-44.93K | ---- | ---- | 83.91%-11.55K | -100.99%-178.94K | 11,241.73%117.21K | ---- | ---- |
| Other non-operating income (expenses) | --4.19K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 335.72%2.98M | 452.17%462.35K | 161.72%465K | 17.02%2.79M | 137.12%2.99M | -33.91%684.48K | -158.72%-131.28K | -451.96%-753.37K | 17.16%2.38M | -47.41%1.26M |
| Income tax | 335.72%790.34K | 452.17%122.52K | 161.72%120.9K | -20.85%609.74K | 40.17%662.79K | -33.91%181.39K | -158.72%-34.79K | -451.96%-195.88K | 4.53%770.35K | -41.88%472.83K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 335.72%2.19M | 452.17%339.82K | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K |
| Net income continuous operations | 335.72%2.19M | 452.17%339.82K | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 335.72%2.19M | 452.17%339.82K | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 335.72%2.19M | 452.17%339.82K | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K |
| Diluted earnings per share | 363.33%0.139 | 450.00%0.021 | 161.11%0.022 | 40.00%0.14 | 200.00%0.15 | -40.00%0.03 | -154.55%-0.006 | -414.29%-0.036 | 150.00%0.1 | 5.57%0.05 |
| Basic earnings per share | 293.33%0.118 | 400.00%0.018 | 152.78%0.019 | 44.44%0.13 | 180.00%0.14 | -25.00%0.03 | -160.00%-0.006 | -414.29%-0.036 | 125.00%0.09 | 5.57%0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data